Differential effects of fenofibrate versus atorvastatin on the concentrations of E-selectin and vascular cellular adhesion molecule-1 in patients with type 2 diabetes mellitus and mixed hyperlipoproteinemia: a randomized cross-over trial
- Simvastatin Reduces Plasma Osteoprotegerin in Type 2 Diabetic Patients With Microalbuminuria. Nellemann, Birgitte; Gormsen, Lars C.; Dollerup, Jens; Schmitz, Ole; Mogensen, Carl E.; Rasmussen, Lars M.; Nielsen, Søren // Diabetes Care;Dec2007, Vol. 30 Issue 12, p3122
The article offers information on the results of a study on the effect of simvastatin on osteoprotegerin (OPG) and adhesion molecules in type 2 diabetic patients at increased risk for cardiovascular disease (CVD) due to persistent microalbuminuria. It states that the findings may reflect a...
- Air pollution and inflammation in type 2 diabetes: a mechanism for susceptibility. O'Neill, M. S.; Veves, A.; Sarnat, J. A.; A. Zanobetti; Gold, D. R.; Economides, P. A.; E. S. Horton; Schwartz, J. // Occupational & Environmental Medicine;Jun2007, Vol. 64 Issue 6, p373
Background: Particulate air pollution has been associated with several adverse cardiovascular health outcomes, and people with diabetes may be especially vulnerable. One potential pathway is inflammation and endothelial dysfunction-processes in which cell adhesion molecules and inflammatory...
- ACCORD and type 2 diabetes. Elliott, William // Alternative Medicine Alert;May2010 Supplement, p1
The article discusses the findings of three Action to Control Cardiovascular Risk in Diabetics (ACCORD) trials among patients with type 2 diabetes. The first study found that intensive therapy, which targeted glycosylated hemoglobin (A1c) at < 6.0%, increased mortality rate and failed to reduce...
- ISCHAEMIC HEART DISEASE. Gorog, Diana; Kapur, Akhil; Khan, Masood; Lindsay, Alistair; Sharp, Andrew // Heart;Mar2006, Vol. 92 Issue 3, p430
The article presents a collection of research studies on ischemic heart disease published in various periodicals. The use of rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction has been assessed. Researchers examine the effects of long-term fenofibrate therapy on...
- Fenofibrate Does Not Prevent Coronary Events. Barry, Henry // American Family Physician;4/15/2006, Vol. 73 Issue 8, p1443
Discusses research on the effects of long-term fenofibrate therapy on cardiovascular events in patients with type 2 diabetes. Reference to a study by A. Keech et al, published in the November 26, 2005 issue of "The Lancet"; Overview of the study methodology; Interpretation of the study findings.
- Aggressive lipid control fails to benefit type 2 diabetics. Campbell, Maude // Drug Topics;Jun2010, Vol. 154 Issue 6, p28
The article reports on the addition of fenofibrate to statin therapy can minimize cardiovascular events in patients with type 2 diabetes. It mentions that the combination lipid treatment can lower the risks of low density of lipoprotein (LDL) to patients with type 2 diabetes. According to...
- Statin benefits outweigh risk of developing diabetes. // Pulse;2/24/2010, Vol. 70 Issue 6, p11
The article explores the benefits of statins that outweigh the risk of developing type 2 diabetes.
- 398 Effect of statins on the course of CHF in patients with type 2 diabetes mellitus. // European Journal of Heart Failure. Supplements;Jun2005, Vol. 4 Issue 1, p88
An abstract of the article "Effect of Statins on the Course of CHF in Patients With Type 2 Diabetes Mellitus," by G. Arutyunov and A. Beituganov is presented.
- Clinical briefs. // New Zealand Doctor;3/10/2010, p24
This section offers clinical news briefs including the role of statins in raising the relative risk of developing type 2 diabetes by nine percent, the risk posed by paroxetine to women taking tamoxifen for breast cancer, and the role of aspirin in helping women with breast cancer survive.